Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johan Bussink

Showing results (161-170 of 220) with videos related to

Pageof 22
Sort By:
Radiology|November 16, 2016
Tumor Delineation and Quantitative Assessment of Glucose Metabolic Rate within Histologic Subtypes of Non-Small Cell Lung Cancer by Using Dynamic <sup>18</sup>F Fluorodeoxyglucose PETTineke W H Meijer, Lioe-Fee de Geus-Oei, Eric P Visser, et al.
Scientific Data|October 24, 2019
Distributed radiomics as a signature validation study using the Personal Health Train infrastructureZhenwei Shi, Ivan Zhovannik, Alberto Traverso, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 19, 2013
Cardiac comorbidity is an independent risk factor for radiation-induced lung toxicity in lung cancer patientsGeorgi Nalbantov, Bas Kietselaer, Katrien Vandecasteele, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 11, 2016
The Impact of Optimal Respiratory Gating and Image Noise on Evaluation of Intratumor Heterogeneity on 18F-FDG PET Imaging of Lung CancerWillem Grootjans, Florent Tixier, Charlotte S van der Vos, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 19, 2008
Correlation of [18F]FMISO autoradiography and pimonidazole [corrected] immunohistochemistry in human head and neck carcinoma xenograftsEsther G C Troost, Peter Laverman, Mariëlle E P Philippens, et al.
Frontiers in Oncology|January 24, 2022
Imaging the Rewired Metabolism in Lung Cancer in Relation to Immune TherapyEvelien A J van Genugten, Jetty A M Weijers, Sandra Heskamp, et al.
Molecular Cancer|November 7, 2013
Combining radiotherapy with MEK1/2, STAT5 or STAT6 inhibition reduces survival of head and neck cancer linesHanneke Stegeman, Johannes H A M Kaanders, Marieke M G Verheijen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 24, 2025
Association between dose to cardiac structures and overall survival: A multivariable analysis in a large, multi-institutional database of stage III NSCLC patients with external validationMiguel Garrett Fernandes, Johan Bussink, Robin Wijsman, et al.
Head & Neck|December 19, 2013
Prognostic value of the proliferation marker Ki-67 in laryngeal carcinoma: results of the accelerated radiotherapy with carbogen breathing and nicotinamide phase III randomized trialSaskia E Rademakers, Ilse J Hoogsteen, Paul F Rijken, et al.
BMC Cancer|February 28, 2014
Systematic analysis of 18F-FDG PET and metabolism, proliferation and hypoxia markers for classification of head and neck tumorsBianca A W Hoeben, Maud H W Starmans, Ralph T H Leijenaar, et al.
Pageof 22

Showing results (161-170 of 220) with videos related to

Sort By:
Pageof 22
Radiology|November 16, 2016
Tumor Delineation and Quantitative Assessment of Glucose Metabolic Rate within Histologic Subtypes of Non-Small Cell Lung Cancer by Using Dynamic <sup>18</sup>F Fluorodeoxyglucose PETTineke W H Meijer, Lioe-Fee de Geus-Oei, Eric P Visser, et al.
Scientific Data|October 24, 2019
Distributed radiomics as a signature validation study using the Personal Health Train infrastructureZhenwei Shi, Ivan Zhovannik, Alberto Traverso, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 19, 2013
Cardiac comorbidity is an independent risk factor for radiation-induced lung toxicity in lung cancer patientsGeorgi Nalbantov, Bas Kietselaer, Katrien Vandecasteele, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 11, 2016
The Impact of Optimal Respiratory Gating and Image Noise on Evaluation of Intratumor Heterogeneity on 18F-FDG PET Imaging of Lung CancerWillem Grootjans, Florent Tixier, Charlotte S van der Vos, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 19, 2008
Correlation of [18F]FMISO autoradiography and pimonidazole [corrected] immunohistochemistry in human head and neck carcinoma xenograftsEsther G C Troost, Peter Laverman, Mariëlle E P Philippens, et al.
Frontiers in Oncology|January 24, 2022
Imaging the Rewired Metabolism in Lung Cancer in Relation to Immune TherapyEvelien A J van Genugten, Jetty A M Weijers, Sandra Heskamp, et al.
Molecular Cancer|November 7, 2013
Combining radiotherapy with MEK1/2, STAT5 or STAT6 inhibition reduces survival of head and neck cancer linesHanneke Stegeman, Johannes H A M Kaanders, Marieke M G Verheijen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 24, 2025
Association between dose to cardiac structures and overall survival: A multivariable analysis in a large, multi-institutional database of stage III NSCLC patients with external validationMiguel Garrett Fernandes, Johan Bussink, Robin Wijsman, et al.
Head & Neck|December 19, 2013
Prognostic value of the proliferation marker Ki-67 in laryngeal carcinoma: results of the accelerated radiotherapy with carbogen breathing and nicotinamide phase III randomized trialSaskia E Rademakers, Ilse J Hoogsteen, Paul F Rijken, et al.
BMC Cancer|February 28, 2014
Systematic analysis of 18F-FDG PET and metabolism, proliferation and hypoxia markers for classification of head and neck tumorsBianca A W Hoeben, Maud H W Starmans, Ralph T H Leijenaar, et al.
Pageof 22